The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
we started it when I was at Yale University Department of Neurology where we have been working on epilepsy and lipid storage diseases and ganglia sites basically is it complex lipid molecules and one of the individuals that I was working with that time Robert you he's my was my mentor at the time he had done some research on ganglia side changes in tumors
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.